Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-05-05 3:28 pm Purchase |
2023-04-28 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
Cowen Financial Products LLC | 1,398,983 5.220% |
1,398,983 (New Position) |
Filing History |
| 2023-02-14 4:00 pm Sale |
2022-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
TANG CAPITAL PARTNERS LP | 2,001,585 7.500% |
-90,168 (-4.31%) |
Filing History |
| 2023-02-14 3:04 pm Purchase |
2022-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
Cormorant Asset Management LP | 1,736,422 6.510% |
333,091 (+23.74%) |
Filing History |
| 2023-02-14 2:33 pm Unchanged |
2022-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
Perceptive Advisors LLC | 1,296,416 4.900% |
0 (Unchanged) |
Filing History |
| 2023-02-14 10:09 am Purchase |
2022-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
RTW Investments, LP | 2,548,125 9.600% |
534,524 (+26.55%) |
Filing History |
| 2023-02-13 5:52 pm Sale |
2022-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
Vivo Capital IX, LLC | 2,262,200 8.500% |
-725,131 (-24.27%) |
Filing History |
| 2023-02-10 10:10 am Unchanged |
2022-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
Flynn James E | 1,324,214 4.960% |
0 (Unchanged) |
Filing History |
| 2023-02-09 11:01 am Sale |
2023-01-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
BlackRock Inc. BLK |
1,326,531 4.900% |
-14,728 (-1.10%) |
Filing History |
| 2023-02-08 1:16 pm Purchase |
2022-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
BlackRock Inc. BLK |
1,341,259 5.000% |
1,341,259 (New Position) |
Filing History |
| 2023-02-03 08:16 am Purchase |
2022-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
TimesSquare Capital Management, LLC | 1,429,310 5.360% |
1,429,310 (New Position) |
Filing History |
| 2022-05-13 4:00 pm Purchase |
2022-05-03 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
TANG CAPITAL PARTNERS LP | 2,091,753 7.900% |
2,091,753 (New Position) |
Filing History |
| 2022-05-11 1:50 pm Purchase |
2022-05-10 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
Flynn James E | 1,324,214 5.040% |
1,324,214 (New Position) |
Filing History |
| 2022-02-14 5:28 pm Unchanged |
2021-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
Perceptive Advisors LLC | 1,296,416 6.300% |
0 (Unchanged) |
Filing History |
| 2022-02-14 4:46 pm Sale |
2021-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
Azamian Bobak R. | 1,426,091 6.800% |
-489,204 (-25.54%) |
Filing History |
| 2022-02-14 4:45 pm Sale |
2021-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
Ackermann Michael | 1,261,666 6.100% |
-205,354 (-14.00%) |
Filing History |
| 2022-02-14 3:01 pm Sale |
2021-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
Cormorant Asset Management LP | 1,403,331 6.790% |
-310,938 (-18.14%) |
Filing History |
| 2022-02-14 08:18 am Sale |
2021-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
RTW Investments, LP | 2,013,601 9.700% |
-450,000 (-18.27%) |
Filing History |
| 2022-02-11 5:21 pm Sale |
2021-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
Vivo Capital IX, LLC | 2,987,331 14.400% |
-257,704 (-7.94%) |
Filing History |
| 2022-01-28 2:09 pm Sale |
2021-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
Frazier Life Sciences IX L.P. | 1,417,157 6.900% |
-500,000 (-26.08%) |
Filing History |
| 2021-02-16 4:37 pm Purchase |
2020-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
FLYING L INVESTMENTS XI LLC | 1,206,051 5.880% |
1,206,051 (New Position) |
Filing History |